These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3567977)

  • 1. Acute myocardial effects of mitoxantrone in the rabbit.
    Tumminello FM; Leto G; Gebbia N; Gebbia V; Russo A; Rausa L
    Cancer Treat Rep; 1987 May; 71(5):529-31. PubMed ID: 3567977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amsacrine (m-AMSA), a new aminoacridine antitumor drug, on the rabbit heart.
    D'Alessandro N; Gebbia N; Crescimanno M; Flandina C; Leto G; Tumminello FM; Messina L
    Cancer Treat Rep; 1983 May; 67(5):467-74. PubMed ID: 6687838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.
    Robert J
    Cell Biol Toxicol; 2007 Jan; 23(1):27-37. PubMed ID: 17041747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological changes and catalase activity in the hearts of CD 1 mice following acute starvation or single doses of doxorubicin, epirubicin or mitoxantrone.
    Crescimanno M; Flandina C; Rausa L; Sanguedolce R; D'Alessandro N
    Chemioterapia; 1988 Feb; 7(1):53-9. PubMed ID: 3163942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute adriamycin cardiotoxicity: morphologic alterations in isolated perfused rabbit heart.
    Taylor AL; Bulkley BH
    Lab Invest; 1982 Nov; 47(5):459-64. PubMed ID: 7132289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
    Koutinos G; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
    Anticancer Res; 2002; 22(2A):815-20. PubMed ID: 12014656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment of new anticancer compound, mitoxantrone, in beagle dogs: comparison with doxorubicin. II. Histologic and ultrastructural pathology.
    Sparano BM; Gordon G; Hall C; Iatropoulos MJ; Noble JF
    Cancer Treat Rep; 1982 May; 66(5):1145-58. PubMed ID: 7083217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
    OKunewick JP; Buffo MJ; Kociban DL
    Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells.
    Kluza J; Marchetti P; Gallego MA; Lancel S; Fournier C; Loyens A; Beauvillain JC; Bailly C
    Oncogene; 2004 Sep; 23(42):7018-30. PubMed ID: 15273722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.
    Jensen RA; Acton EM; Peters JH
    Cancer Res; 1984 Sep; 44(9):4030-9. PubMed ID: 6744318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.
    Tham P; Dougherty W; Iatropoulos MJ; Gordon G; James VC; Hall C; Noble JF
    Am J Pathol; 1987 Jul; 128(1):121-30. PubMed ID: 3605309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interval-force relationship: a technique for evaluating the cardiac toxicity of anthracycline analogs.
    Breed JG; Zimmerman AN; Meyler FL; Pinedo HM
    Cancer Treat Rep; 1979 May; 63(5):869-73. PubMed ID: 455328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
    Robert J
    Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin.
    Platel D; Bonoron-Adèle S; Dix RK; Robert J
    Br J Cancer; 1999 Sep; 81(1):24-7. PubMed ID: 10487608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial effects of mitoxantrone and doxorubicin in the mouse and guinea pig.
    Perkins WE; Schroeder RL; Carrano RA; Imondi AR
    Cancer Treat Rep; 1984 Jun; 68(6):841-7. PubMed ID: 6733698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protectors against doxorubicin-induced cardiotoxicity: flavonoids.
    Bast A; Kaiserová H; den Hartog GJ; Haenen GR; van der Vijgh WJ
    Cell Biol Toxicol; 2007 Jan; 23(1):39-47. PubMed ID: 17063376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cells.
    Shipp NG; Dorr RT; Alberts DS; Dawson BV; Hendrix M
    Cancer Res; 1993 Feb; 53(3):550-6. PubMed ID: 8425187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental study of the subacute toxicity of mitoxantrone and doxorubicin in rats (subcutaneous and/or intraperitoneal route)].
    Bouhour JB; Chiffoleau S; Delajartre AY
    Arch Mal Coeur Vaiss; 1986 Jul; 79(8):1238-44. PubMed ID: 3096251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cardiac effects of fluvoxamine and other antidepressants in conscious rabbits.
    Wouters W; Deiman W
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):197-207. PubMed ID: 6411017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity.
    Sterba M; Popelová O; Simunek T; Mazurová Y; Potácová A; Adamcová M; Kaiserová H; Ponka P; Gersl V
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1336-47. PubMed ID: 17003229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.